Provides limitations on overlapping control between insurance companies and pharmacy benefits managers and pharmacies; requires divestment of the interest in one or more insurance companies and pharmacy benefits managers; prohibits insurance companies, pharmacies, and pharmacy benefit managers found in violation of such provisions from receiving payment from certain state programs.